Laura Bessen - 29 Jul 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 16:23:42 UTC
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +41,200 $0.000000 41,200 29 Jul 2022 Common Stock 41,200 $9.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares underlying this option shall vest and become exercisable on July 29, 2023, with the remainder vesting in eight equal quarterly installments thereafter.